| dc.contributor.author | Paracha, Martin | |
| dc.contributor.author | Olsson, Jonas | |
| dc.date.accessioned | 2017-06-28T09:16:46Z | |
| dc.date.available | 2017-06-28T09:16:46Z | |
| dc.date.issued | 2017-06-28 | |
| dc.identifier.uri | http://hdl.handle.net/2077/52760 | |
| dc.description.abstract | This study investigated if financial advisors contribute to value creation in M&A transactions in the pharmaceutical industry, using an event study methodology. Based on 294 transactions worldwide between 2012-2016, an average of 3.03% positive cumulative abnormal return was found, significant at a 1% level. Using OLS and Heckman least square regressions, no significant effect of employing a financial advisor was found, no matter if the advisor was a top-tier or non-top-tier financial advisor. | sv |
| dc.language.iso | eng | sv |
| dc.relation.ispartofseries | 201706:282 | sv |
| dc.relation.ispartofseries | Uppsats | sv |
| dc.subject | M&A | sv |
| dc.subject | Pharmaceutical | sv |
| dc.subject | Financial advisory | sv |
| dc.subject | Industrial specialization | sv |
| dc.subject | Asymmetric information | sv |
| dc.subject | Abonormal retur | sv |
| dc.title | Does financial advisory add value to M&A transactions in the pharmaceutical industry? | sv |
| dc.title.alternative | Does financial advisory add value to M&A transactions in the pharmaceutical industry? | sv |
| dc.type | text | |
| dc.setspec.uppsok | SocialBehaviourLaw | |
| dc.type.uppsok | M2 | |
| dc.contributor.department | University of Gothenburg/Department of Economics | |
| dc.contributor.department | Göteborgs universitet/Institutionen för nationalekonomi med statistik | |
| dc.contributor.department | University of Gothenburg/Department of Business Administration | |
| dc.contributor.department | Göteborgs universitet/Företagsekonomiska institutionen | |
| dc.type.degree | Student essay | |
